Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized, 3-arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-valent Pneumococcal CRM197-conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7

NCT00617760 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00617760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00617760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized, 3-arm, Phase 3B Clinical Study to Investigate the Safety and Immunogenicity of a Concomitant Administration of Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate (MenC-TT) Vaccine and 7-valent Pneumococcal CRM197-conjugate Vaccine (PCV7) in Toddlers Previously Immunized During Infancy With PCV7
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2009
Enrollment
330 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

invasive pneumococcal disease (ipd), neisseria meningitidis (bacterial meningitis)